Search

Filters
Types

Sign up for our free
equity research notes

Register
2708 Results for ‘Review’
Embed
Alliance Trust – Coming into its own

Alliance Trust Investment companies | Annual overview | 15 November 2023 Coming into its own Alliance Trust’s (ATST) diversified blend of active managers could be the key factor behind the trust’s performance being ahead of global equities over multiple time frames. ATST appears to have been able to capture benefits of the sentiment shifts in global […]

Tokyo skyline
Alliance Trust – Coming into its own

Alliance Trust Investment companies | Annual overview | 15 November 2023 Coming into its own Thanks in no small part to Alliance Trust’s (ATST) diversified blend of actively managed strategies, the trust’s performance has been ahead of global equity markets over multiple time frames. ATST has been able to capture benefits of the major sentiment shifts […]

Tokyo skyline
Alliance Trust – Coming into its own

Alliance Trust Investment companies | Annual Overview | 15 November 2023 Coming into its own Thanks in no small part to Alliance Trust’s (ATST) diversified blend of active managers, the trust’s performance has been ahead of global equities over multiple time frames. ATST has been able to capture benefits of the major sentiment shifts in global […]

Tokyo skyline
AVI Global comfortably beats benchmark and ups dividend 6%

AVI Global Trust has announced its annual results for the year ended 30 September 2023, during which it has provided NAV and share price total returns of 15.3% and 14.8% respectively, both comfortably ahead of its comparator benchmarks, the MSCI All Country World Index and the MSCI All Country World ex-US Index, which returned 10.5% […]

Volta Finance “offers excellent value at these pricing levels”

Volta Finance (VTA) has published its annual results for the year ended 31 July 2023, during which its NAV per share has grown to €6.45 at 31 July 2023, an increase of 3.7% on the €6.22 recorded at 31 July 2022, and the dividend has been maintained at 8.0% of NAV, equating to a yield […]

Foresight Sustainable Forestry update notes widening discount

Foresight Sustainable Forestry has updated on progress over the six months ended 30 September 2023. The board says that it is disappointed to see the share price trade at a discount to NAV. Together with the investment manager it says that it is: Reviewing planting and harvesting timetables to optimise cash flows. Advancing non-core asset […]

inside a forest of moss covered trees
Downing Strategic will commence managed wind down

The board and manager of Downing Strategic Micro-Cap have decided that, with the continuing negative sentiment towards smaller companies and small investment trusts, it is timely to begin a managed wind-down of the company, with the intention to make the first return to shareholders of at least 20% of capital in early 2024. This will […]

Downing Strategic Micro says underlying discount growing
QuotedData’s morning briefing 9 November 2023 – MUT, JZCP, HOT, DGN, AEI, HOME, RGL, SHED

In QuotedData’s morning briefing 9 November 2023: Murray Income says it will pay three interim dividends of 9.5p in December, March 2024 and June 2024. Up from 8.25p for the previous financial year. The directors are trying to rebalance the trust’s quarterly dividends in order to accelerate payments to shareholders. As a result, the board […]

a cup of tea, a croissant and some magazines
Fidelity Special Values outperforms despite small-cap bias

Fidelity Special Values (FSV) announced its final results for the year with a NAV total return of 5.9% and a 5.6% share price total return against a Benchmark return of 5.2%. The company’s overweight  to banks was the largest contributor to performance with the advisor noting that while the performance may look unremarkable at face […]

Baillie Gifford UK Growth Trust BGUK
Another steady year for International Biotechnology

International Biotechnology Trust (IBT) announced its results for the year ended 31 August 2023. The share price total return rose by 3% over the financial year to the end of August 2023, while the benchmark NASDAQ Biotechnology Index (NBI) fell by 1.4% over the same period. The company’s Net Asset Value rose by 2.7%. Most of […]